237 related articles for article (PubMed ID: 17222462)
1. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Aktas O; Waiczies S; Zipp F
J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
[TBL] [Abstract][Full Text] [Related]
2. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration and -protection in autoimmune CNS inflammation.
Diem R; Sättler MB; Bähr M
J Neuroimmunol; 2007 Mar; 184(1-2):27-36. PubMed ID: 17188756
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration in autoimmune CNS inflammation.
Herz J; Zipp F; Siffrin V
Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
[TBL] [Abstract][Full Text] [Related]
5. Macrophages and neurodegeneration.
Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
[TBL] [Abstract][Full Text] [Related]
6. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
Hauser SL; Oksenberg JR
Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
[TBL] [Abstract][Full Text] [Related]
7. Future neuroprotective strategies.
Sättler MB; Bähr M
Exp Neurol; 2010 Sep; 225(1):40-7. PubMed ID: 19716365
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
[TBL] [Abstract][Full Text] [Related]
9. [Neuronal injury in multiple sclerosis].
Correale J; Meli F; Ysrraelit C
Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
[TBL] [Abstract][Full Text] [Related]
10. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
Charil A; Filippi M
J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Ellwardt E; Zipp F
Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
[TBL] [Abstract][Full Text] [Related]
13. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
Offner H
J Neurosci Res; 2004 Dec; 78(5):603-24. PubMed ID: 15515048
[TBL] [Abstract][Full Text] [Related]
14. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
15. Use of stem cells for the treatment of multiple sclerosis.
Karussis D; Kassis I
Expert Rev Neurother; 2007 Sep; 7(9):1189-201. PubMed ID: 17868017
[TBL] [Abstract][Full Text] [Related]
16. New insights into adaptive immunity in chronic neuroinflammation.
Siffrin V; Brandt AU; Herz J; Zipp F
Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of neurodegeneration in multiple sclerosis.
Lassmann H; van Horssen J
FEBS Lett; 2011 Dec; 585(23):3715-23. PubMed ID: 21854776
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
Petratos S; Azari MF; Ozturk E; Papadopoulos R; Bernard CC
J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
[TBL] [Abstract][Full Text] [Related]
19. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
Mirowska-Guzel D
Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
Humle Jorgensen S; Sorensen PS
J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
